Abstract: The invention provides a therapeutic product for dental use, which comprises an active ingredient cannabidiol and it further comprises squalane as solvent, wherein the product is in the form of dental gel. The product may contain hyaluronic acid or a pharmaceutically acceptable salt thereof. The product is suitable in particular for treatment and/or prevention of gingival inflammation, periodontitis and periimplantitis.

Abstract: A pharmaceutical composition in the form of suppository, containing cannabidiol, hyaluronic acid or a salt thereof, and a suppository base containing water is described. The pharmaceutical composition is particularly suitable for use in regenerating and/or healing damaged tissues, or in relieving and/or alleviating pain and inflammation, or in alleviating the symptoms associated with menopause and/or pre-menstrual syndrome.